Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Precedex and Dormicum for Pediatric Dental Sedation
NCT03827408Phase 2Completed
- Start
- Nov 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dexmedetomidine in Dental anxiety. Started Nov 2017; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Dental anxiety
Beyond the preview
Go deeper on NCT03827408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03827408.